Medicines Notices




2602 NEW ZEALAND GAZETTE No. 108

Active Ingredient(s): Piperazine oestrone sulphate 1.5 mg.
Dosage Form: Tablet.
NZ Sponsor: Pharmacia & Upjohn.
Manufacturer(s): Abbott Health Products, Pharmaceutical Products Plant, Cruce Davila, Barceloneta, Spain.

Product: Ogen.
Active Ingredient(s): Piperazine oestrone sulphate 3 mg.
Dosage Form: Tablet.
NZ Sponsor: Pharmacia & Upjohn.
Manufacturer(s): Abbott Health Products, Pharmaceutical Products Plant, Cruce Davila, Barceloneta, Spain.

Product: Pulmicort Aerosol.
Active Ingredient(s): Budesonide 200 µg/dose.
Dosage Form: Aerosol inhaler, metered dose.
NZ Sponsor: AstraZeneca Limited.
Manufacturer(s): 3M Health Care (UK) Limited, Loughborough, Leicestershire, England.

Product: Pulmicort Nebulising Solution.
Active Ingredient(s): Budesonide 0.25 mg/mL.
Dosage Form: Suspension for inhalation.
NZ Sponsor: AstraZeneca Limited.
Manufacturer(s): Astra Pharmaceutical Production AB, Södertälje, Sweden.
Astra Pharmaceuticals Pty Limited, North Ryde, New South Wales, Australia.

Product: Pulmicort Nebulising Solution.
Active Ingredient(s): Budesonide 0.5 mg/mL.
Dosage Form: Suspension for inhalation.
NZ Sponsor: AstraZeneca Limited.
Manufacturer(s): Astra Pharmaceutical Production AB, Södertälje, Sweden.
Astra Pharmaceuticals Pty Limited, North Ryde, New South Wales, Australia.

Product: Pulmicort Turbuhaler.
Active Ingredient(s): Budesonide 100 µg/dose.
Dosage Form: Powder for inhalation.
NZ Sponsor: AstraZeneca Limited.
Manufacturer(s): ASP SA (Astra Pharm Prod AB), Dunkerque, France.
Astra Pharmaceutical Production AB, Södertälje, Sweden.

Product: Pulmicort Turbuhaler.
Active Ingredient(s): Budesonide 200 µg/dose.
Dosage Form: Powder for inhalation.
NZ Sponsor: AstraZeneca Limited.
Manufacturer(s): ASP SA (Astra Pharm Prod AB), Dunkerque, France.
Astra Pharmaceutical Production AB, Södertälje, Sweden.

Product: Pulmicort Turbuhaler.
Active Ingredient(s): Budesonide 400 g/dose.
Dosage Form: Powder for inhalation.
NZ Sponsor: AstraZeneca Limited.
Manufacturer(s): ASP SA (Astra Pharm Prod AB), Dunkerque, France.
Astra Pharmaceutical Production AB, Södertälje, Sweden.

Dated this 30th day of August 1999.

G. R. BOYD,
Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).

go6420



Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1999, No 108


NZLII PDF NZ Gazette 1999, No 108





✨ LLM interpretation of page content

🏥 Consent to the Distribution of Changed Medicines (continued from previous page)

🏥 Health & Social Welfare
30 August 1999
Medicines Act, Changed Medicines, Ogen, Piperazine oestrone sulphate, Tablet, Pharmacia & Upjohn, Pulmicort, Budesonide, Aerosol inhaler, Suspension for inhalation, Powder for inhalation, AstraZeneca Limited
  • G. R. Boyd, Chief Advisor, Safety and Regulation